MBRX icon

Moleculin Biotech
MBRX

Overview Fund Activity

24 hedge funds and large institutions have $1.58M invested in Moleculin Biotech in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Holders
24
Holders Change
+2
Holders Change %
+9.09%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CIBC World Market
1
CIBC World Market
Ontario, Canada
$170K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$43K
3
Bank of New York Mellon
3
Bank of New York Mellon
New York
$36K
4
Northern Trust
4
Northern Trust
Illinois
$50K
5
WIC
5
Whitegate Investment Counselors
New Hampshire
$127K

Top Sellers

1
PNC Financial Services Group
1
PNC Financial Services Group
Pennsylvania
$0
2
Commonwealth Equity Services
2
Commonwealth Equity Services
Massachusetts
$10K
3
LNWWM
3
Laird Norton Wetherby Wealth Management
California
$10K
4
OIA
4
OneDigital Investment Advisors
Kansas
$0
5
AWM
5
Avondale Wealth Management
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AWM
26
Avondale Wealth Management
Texas
– -$4K -30 Closed
1
2